Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid is a complex chemical compound with a diverse chemical skeleton. It contains several functional groups, including a methoxy group, a methyl group, two dioxo groups, a hexahydrooxazolo group, a pyridine ring, a pyrazine ring, and a carboxylic acid group. These functional groups suggest that the compound may have a wide range of applications in various fields, such as organic chemistry, pharmaceutical sciences, and materials science. However, it is important to note that specific properties, usage, or safety information about this particular chemical compound may not be readily available, as it may not have been fully characterized or studied yet.

1335210-24-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid

    Cas No: 1335210-24-6

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • SAGECHEM/(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid

    Cas No: 1335210-24-6

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier
  • 1335210-24-6 Structure
  • Basic information

    1. Product Name: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid
    2. Synonyms: Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid, 2,3,5,7,11,11a-hexahydro-6-methoxy-3-methyl-5,7-dioxo-, (3S,11aR)-;(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide;(3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid
    3. CAS NO:1335210-24-6
    4. Molecular Formula: C13H14N2O6
    5. Molecular Weight: 294.26006
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 1335210-24-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 556.1±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.56±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 5.46±0.40(Predicted)
    10. CAS DataBase Reference: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(1335210-24-6)
    12. EPA Substance Registry System: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(1335210-24-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1335210-24-6(Hazardous Substances Data)

1335210-24-6 Usage

Uses

Used in Organic Chemistry:
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid is used as a building block for the synthesis of more complex molecules due to its diverse functional groups and unique structure.
Used in Pharmaceutical Sciences:
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid is used as a potential drug candidate for the development of new therapeutic agents, given its complex structure and the presence of various functional groups that may interact with biological targets.
Used in Materials Science:
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid is used as a component in the development of new materials with specific properties, such as improved stability, reactivity, or selectivity, owing to its unique chemical structure and functional groups.

Check Digit Verification of cas no

The CAS Registry Mumber 1335210-24-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,5,2,1 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1335210-24:
(9*1)+(8*3)+(7*3)+(6*5)+(5*2)+(4*1)+(3*0)+(2*2)+(1*4)=106
106 % 10 = 6
So 1335210-24-6 is a valid CAS Registry Number.

1335210-24-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S,11aR)-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid

1.2 Other means of identification

Product number -
Other names (3S,11aR)-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2- a]pyrido[1,2-d]pyrazine-8-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1335210-24-6 SDS

1335210-24-6Relevant articles and documents

Cabotegravir derivative with biological activity as well as preparation method and application thereof

-

Paragraph 0068-0070, (2021/10/27)

The invention belongs to the technical field of chemical synthesis of medicines, and particularly relates to a cabotegravir derivative with biological activity as well as a preparation method and application thereof. The structural formula of the cabotegravir derivative is shown in the specification, wherein R1 is methyl or hydrogen; R2 is methylene, isopropyl, phenyl, benzyl, a nitrogen-containing heterocyclic ring, a sulfur-containing heterocyclic ring or an oxygen-containing heterocyclic ring; and R3 is hydrogen, methyl, ethyl, phenyl, benzyl, nitrogen-containing heterocyclic ring, sulfur-containing heterocyclic ring or oxygen-containing heterocyclic ring. The preparation method comprises the following steps of: carrying out deprotection on 1-(2, 2-dimethoxyethyl)-1, 4-dihydro-3-methoxy-4-oxo-2, 5-pyridinedicarboxylic acid-2-methyl ester to obtain aldehyde, cyclizing the aldehyde with aminobutanol, and carrying out acylation reaction on the cyclized aldehyde and an amino compound; or firstly reacting the aldehyde with an amino compound, and then cyclizing with aminopropanol; and finally, carrying out click reaction with azide to obtain a target compound. The derivative provided by the invention has proliferation inhibition activity on human tumor cells.

CONTINUES FLOW PROCESS FOR THE PREPARATION OF ACTIVE PHARMACEUTICAL INGREDIENTS - POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVES AND INTERMEDIATES THEREOF

-

, (2019/09/04)

The present invention discloses continues flow process for the preparation of polycyclic carbamoyl pyridone derivatives and intermediates thereof. In particular, the present invention discloses a process for the preparation of intermediate. Formule (V).

An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor

Wang, Huan,Kowalski, Matthew D.,Lakdawala, Ami S.,Vogt, Frederick G.,Wu, Lianming

supporting information, p. 564 - 567 (2015/03/04)

A novel synthesis of GSK1265744, a potent HIV integrase inhibitor, is described. The synthesis is highlighted by an efficient construction of the densely functionalized pyridinone core as well as a highly diastereoselective formation of the acyl oxazolidine moiety. The latter exploits the target molecules ability to chelate to Mg2+, a key feature in the integrase inhibitors mechanism of action.

PROCESS FOR PREPARING CARBAMOYLPYRIDONE DERIVATIVES AND INTERMEDIATES

-

, (2011/10/13)

The present invention relates to the preparation of carbamoylpyridone derivatives and intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1335210-24-6